Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,356 | 21,170 | 19,986 | 18,385 | 34,132 |
| Marketable Securities | 11,462 | 20,971 | 27,444 | 13,357 | N/A |
| TOTAL | $38,033 | $43,480 | $47,984 | $33,022 | $35,387 |
| Non-Current Assets | |||||
| PPE Net | 236 | 259 | 280 | 309 | 338 |
| Other Non-Current Assets | 240 | 240 | 300 | 300 | 299 |
| TOTAL | $476 | $499 | $580 | $609 | $637 |
| Total Assets | $38,509 | $43,979 | $48,564 | $33,631 | $36,024 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,016 | 291 | 226 | 1,193 | 474 |
| Accrued Expenses | 2,004 | 8,949 | 8,868 | 2,944 | 2,549 |
| TOTAL | $9,020 | $9,240 | $9,094 | $4,137 | $3,023 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,020 | $9,240 | $9,094 | $4,137 | $3,023 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 442 | 442 | 440 | 440 | 419 |
| Common Shares | 18 | 18 | 18 | 18 | 17 |
| Retained earnings | -195,822 | -189,741 | -184,190 | -171,883 | -166,275 |
| Other shareholders' equity | 21,519 | 21,509 | 21,529 | -7 | 0 |
| TOTAL | $29,489 | $34,739 | $39,470 | $29,494 | $33,001 |
| Total Liabilities And Equity | $38,509 | $43,979 | $48,564 | $33,631 | $36,024 |